Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Supply Chain, Digital Technologies, Standards & Regulation, Small Molecules

Creating Digital Infrastructure

This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques. Read more about The Small Molecule Manufacturer here https://themedicinemaker.com/manufacture/small-but-never-forgotten


The pharmaceutical supply chain connects stakeholders from across the world in their shared goal of manufacturing effective medicines for patients. But the complex (and often international) transactions required to develop finished products provide counterfeiters with opportunities to infiltrate and introduce fake or falsified products. In emerging markets, where pharmaceutical supply chains and infrastructure may be frail, the problem is further exacerbated; in some countries, counterfeits account for 40–50 percent of available medicines (1). The consequence of this supply chain fragility is often death; many unwitting patients succumb to silent killers: falsified medicines with harmful or no therapeutic effects.

Manufacturers and other stakeholders are doing their best to mend these supply chain cracks. With serialization and traceability legislation in place across most countries, companies have the opportunity to improve end-to-end supply chain visibility and lessen the risk associated with counterfeit products. Although many companies have implemented or are implementing the technology to meet these laws, the timeframe for adoption varies across regions and implementation of software and solutions is at the discretion of individual companies.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Shabbir Dahod

Shabbir Dahod is Chief Executive Officer at Tracelink

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register